Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ctDNA Monitoring”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05375370
What this trial is testing

Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Rouen 150
Not applicableActive Not RecruitingNCT05914792
What this trial is testing

Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery

Who this might be right for
Breast Cancer
University of Pittsburgh 49
Not applicableStudy completedNCT03416933
What this trial is testing

Therapeutic Drug Monitoring of BRAF-mutated Advanced Melanoma

Who this might be right for
Melanoma (Skin)
Institut de Cancérologie de Lorraine 35
Large-scale testing (Phase 3)Not Yet RecruitingNCT07717450
What this trial is testing

Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.

Who this might be right for
Metastatic Invasive Breast Cancer
UNICANCER 370
Not applicableUnknownNCT05167604
What this trial is testing

Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungNext-Generation SequencingChemotherapy, Adjuvant+2 more
Tang-Du Hospital 150
Not applicableLooking for participantsNCT05917106
What this trial is testing

Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

Who this might be right for
CarcinomaRenal Cell CarcinomaRCC+2 more
Jinling Hospital, China 450
Not applicableNot Yet RecruitingNCT07799649
What this trial is testing

CtDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 150
Not applicableUnknownNCT06178809
What this trial is testing

Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA After Systemic Therapy of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Singlera Genomics Inc. 475
Not applicableLooking for participantsNCT07356882
What this trial is testing

European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Assistance Publique - Hôpitaux de Paris 400
Not applicableNot Yet RecruitingNCT07751588
What this trial is testing

Plasma ctDNA Monitoring in Pediatric Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 25
Not applicableUnknownNCT05578625
What this trial is testing

CtDNA Methylation Sequencing for Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 66
Not applicableLooking for participantsNCT07257471
What this trial is testing

Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy

Who this might be right for
Lung Cancer (NSCLC)
Beijing Haidian Hospital 30
Not applicableStudy completedNCT03172156
What this trial is testing

CtDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

Who this might be right for
Non-small Cell Lung Cancer Stage I
Sun Yat-sen University 100
Not applicableUnknownNCT05814224
What this trial is testing

Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA

Who this might be right for
Hormone Receptor Positive Breast CarcinomaBreast NeoplasmsNeoplasms, Breast+4 more
Centro di Riferimento Oncologico - Aviano 164
Not applicableStudy completedNCT04813627
What this trial is testing

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

Who this might be right for
Colorectal Cancer Stage IIColorectal Cancer Stage III
BioNTech SE 2,079
Not applicableUnknownNCT05858242
What this trial is testing

Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer

Who this might be right for
Breast Cancer
Singlera Genomics Inc. 100
Not applicableLooking for participantsNCT05802407
What this trial is testing

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer

Who this might be right for
Pancreatic CancerResectable Carcinoma
Peking Union Medical College Hospital 100
Very early researchEnrolling By InvitationNCT07285434
What this trial is testing

Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Squamous Lung Cancer With FGFR1 AmplificationNon-Squamous Non Small Cell Lung Cancer
Biogenea Pharmaceuticals Ltd. 90
Not applicableUnknownNCT03664843
What this trial is testing

Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients

Who this might be right for
CarcinomaNon-small Cell Lung CancerLung Neoplasm
First Hospital of Shijiazhuang City 120
Not applicableLooking for participantsNCT06606028
What this trial is testing

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and NeckSquamous Cell Carcinoma Head and Neck Cancer (HNSCC)Squamous Cell Carcinoma of Skin+1 more
University of California, San Francisco 250
Next Page